Pancreatic Neoplasms: all 3,310 studies
Page 29 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.
- Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETsCompletedNCT01263353Phase 1
- Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally InvasiveCompletedNCT01262040Not applicable
- Combination With Gemcitabine in Advanced Pancreatic CancerCompletedNCT01251640Phase 1/2
- Reconstruction Method and Delayed Gastric Emptying After Pancreatic SurgeryCompletedNCT01248663Not applicable
- Study of Intratumoral Hypoxia Using Pre-operative Administration of PimonidazoleCompletedNCT01248637
- Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With SurgeryCompletedNCT01234935Phase 2
- Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid TumorsTerminatedNCT01233505Phase 1
- Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic AdenocarcinomaCompletedNCT01219829
- Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment FailureStatus unknownNCT01219192Phase 1
- Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic CancerStatus unknownNCT01218880Phase 1
- Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine TumorsTerminatedNCT01215578Phase 2
- Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With CancerTerminatedNCT01212887Phase 1
- Metformin Combined With Chemotherapy for Pancreatic CancerCompletedNCT01210911Phase 2
- A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor ResponseCompletedNCT01209962
- Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine CarcinomaCompletedNCT01204476Phase 1
- The Clinical,Radiologic,Pathologic and Molecular Marker Characteristics of Pancreatic Cysts StudyCompletedNCT01202136
- Gem-TABS in Unresectable Pancreatic CarcinomaCompletedNCT01198821Phase 1
- Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer PatientsTerminatedNCT01198522Phase 1
- A Study of Therapy Selected by Molecular/Metabolic Profiling in Patients With Previously Treated Metastatic Pancreatic CancerCompletedNCT01196247Phase 2
- RO4929097 Before Surgery in Treating Patients With Pancreatic CancerTerminatedNCT01192763Phase 1
- Comparison of Metal and Plastic Stents for Preoperative Biliary DecompressionCompletedNCT01191814Not applicable
- Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic CancerCompletedNCT01191684Phase 1
- A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT01189929Phase 1
- Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the PancreasCompletedNCT01188785Phase 1
- Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic CancerCompletedNCT01186731Phase 2
- Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma PancreasStatus unknownNCT01182831Phase 1
- A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT01181245Phase 1
- Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic CancerCompletedNCT01175733Phase 1/2
- Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic CancerTerminatedNCT01167816Phase 1
- Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic CancerTerminatedNCT01167738Phase 2
- A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric AdenocarcinomaCompletedNCT01166490Phase 1
- Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic AdenocarcinomaCompletedNCT01161186Phase 1
- Registry Study - Whipple at the Splenic ArteryCompletedNCT01155882
- Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic CancerCompletedNCT01150630Phase 2
- Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid TumorsCompletedNCT01145456Phase 1
- Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsCompletedNCT01131234Phase 1
- A Pilot Study to Evaluate the Efficacy and Safety of Neoadjuvant Chemoradiotherapy With Capecitabine, . . .WithdrawnNCT01130701Phase 2
- A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic CancerCompletedNCT01130142Phase 1/2
- Frequency of Methods of Local Invasion of Pancreatic AdenocarcinomaCompletedNCT01129167
- Identify the Clinical Significance and Potential Implications of Peritoneal Washing Cytology (PWC) in Patients With Pancreatic CancerStatus unknownNCT01127815
- Randomized Study With Oxaliplatin in 2nd Line Pancreatic CancerCompletedNCT01121848Phase 3
- Tomotherapy in Locally Advanced Gallbladder and Pancreatic CancersCompletedNCT01118897Phase 1/2
- Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas CancerStatus unknownNCT01111591Phase 4
- Stool Testing for Pancreatic CancerCompletedNCT01104129
- Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN)CompletedNCT01104077
- Validation of a Mouse Model of Pancreatic CarcinogenesisTerminatedNCT01103128
- MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT01098344Phase 1
- Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer DetectionWithdrawnNCT01094626Not applicable
- Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine InsufficiencyWithdrawnNCT01094600Not applicable
- The Role of Meat-borne Carcinogens in Pancreatic CancerWithdrawnNCT01092689Phase 1
- Evaluation of Nelfinavir and Chemoradiation for Pancreatic CancerTerminatedNCT01086332Phase 1
- Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic CancerCompletedNCT01077986Phase 1/2
- Study of S-1 as Second Line Treatment on Advanced Pancreatic CancersStatus unknownNCT01074996Phase 2
- Immunotherapy Study for Surgically Resected Pancreatic CancerCompletedNCT01072981Phase 3
- Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic CancerCompletedNCT01068327Phase 1
- Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)Status unknownNCT01065870Phase 2/3
- A Study of Locally Advanced Pancreatic CancerStatus unknownNCT01063192Phase 2
- Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic NeoplasmsWithdrawnNCT01057355Phase 1
- A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic CancerCompletedNCT01051284Phase 1
- A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU)TerminatedNCT01050426Phase 2
- A Research Trial of High Dose Vitamin C and Chemotherapy for Metastatic Pancreatic CancerCompletedNCT01049880Phase 1
- Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic CancerCompletedNCT01048320Phase 1
- Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for AdenocarcinomaWithdrawnNCT01045941Phase 2
- A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic CancerTerminatedNCT01042028Phase 1/2
- Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of OddiCompletedNCT01041612Phase 4
- QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal CancerCompletedNCT01040000Phase 1/2
- Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT01032057Phase 2
- A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic CancerCompletedNCT01028495Phase 2
- Low Dose Radiation to Improve T-Cell Infiltration in Pancreatic CancerCompletedNCT01027221Not applicable
- Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic CancerTerminatedNCT01025882Phase 1
- A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic CancerTerminatedNCT01025570Phase 1
- A Study of the Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic CancerCompletedNCT01019382Phase 2
- Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic CancerWithdrawnNCT01017822Phase 1/2
- Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal CancerCompletedNCT01016639Phase 1/2
- Study of CellCept for Advanced Pancreatic CancerCompletedNCT00997958Phase 1
- A Phase III Study of Pancreatic CancerCompletedNCT00994721
- High Dose Somatostatin Analogues in Neuroendocrine TumorsCompletedNCT00990535Phase 2
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerCompletedNCT00987766Phase 1
- Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine NeoplasiaCompletedNCT00985777Phase 1
- Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic CancerCompletedNCT00983268Phase 1
- Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine HydrochlorideCompletedNCT00981162Phase 1
- RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant ObstructionCompletedNCT00980889Phase 4
- Trial of Endoscopic Ultrasound (EUS) - Guided Celiac Plexus NeurolysisCompletedNCT00974948Phase 3
- Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.CompletedNCT00974610
- C-VISA BikDD: Liposome in Advanced Pancreatic CancerWithdrawnNCT00968604Phase 1
- Endoscopic Ultrasound (EUS) Guided-Celiac Plexus Neurolysis (CPN) in Unresectable Pancreatic CancerCompletedNCT00968175Not applicable
- Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic CancerCompletedNCT00967603Phase 2
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid TumorsCompletedNCT00967577Phase 1
- Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic CancerTerminatedNCT00967291Phase 2
- Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic CancerCompletedNCT00966706Phase 2
- Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00962312Phase 2
- Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic CancerCompletedNCT00960284Phase 2/3
- Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic CancerCompletedNCT00954525Phase 1
- Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver CancerCompletedNCT00950144
- Trial of Simvastatin and Gemcitabine in Pancreatic Cancer PatientsCompletedNCT00944463Phase 2
- Intra-ductal Confocal Endomicroscopy for Characterization of Pancreas and Bile Duct TumorCompletedNCT00930410Not applicable
- Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With GemcitabineCompletedNCT00923299Phase 1/2
- Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic CancerCompletedNCT00922896Phase 2
- Parenteral Nutrition Support for Patients With Pancreatic CancerCompletedNCT00919659Phase 2
- Gemcitabine (GFF) in Patients With Pancreatic CancerCompletedNCT00919282Phase 2